1. Home
  2. COEP vs BATL Comparison

COEP vs BATL Comparison

Compare COEP & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • BATL
  • Stock Information
  • Founded
  • COEP 2017
  • BATL 1987
  • Country
  • COEP United States
  • BATL United States
  • Employees
  • COEP N/A
  • BATL N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • BATL Oil & Gas Production
  • Sector
  • COEP Health Care
  • BATL Energy
  • Exchange
  • COEP Nasdaq
  • BATL Nasdaq
  • Market Cap
  • COEP 32.4M
  • BATL 29.9M
  • IPO Year
  • COEP N/A
  • BATL N/A
  • Fundamental
  • Price
  • COEP $11.54
  • BATL $1.64
  • Analyst Decision
  • COEP
  • BATL
  • Analyst Count
  • COEP 0
  • BATL 0
  • Target Price
  • COEP N/A
  • BATL N/A
  • AVG Volume (30 Days)
  • COEP 135.7K
  • BATL 126.6K
  • Earning Date
  • COEP 03-25-2025
  • BATL 03-28-2025
  • Dividend Yield
  • COEP N/A
  • BATL N/A
  • EPS Growth
  • COEP N/A
  • BATL N/A
  • EPS
  • COEP N/A
  • BATL N/A
  • Revenue
  • COEP N/A
  • BATL $191,482,000.00
  • Revenue This Year
  • COEP N/A
  • BATL $2.21
  • Revenue Next Year
  • COEP N/A
  • BATL N/A
  • P/E Ratio
  • COEP N/A
  • BATL N/A
  • Revenue Growth
  • COEP N/A
  • BATL N/A
  • 52 Week Low
  • COEP $2.31
  • BATL $1.31
  • 52 Week High
  • COEP $13.70
  • BATL $7.37
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • BATL 38.87
  • Support Level
  • COEP $8.65
  • BATL $1.74
  • Resistance Level
  • COEP $13.70
  • BATL $2.12
  • Average True Range (ATR)
  • COEP 2.11
  • BATL 0.20
  • MACD
  • COEP -0.24
  • BATL 0.04
  • Stochastic Oscillator
  • COEP 61.22
  • BATL 1.30

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About BATL Battalion Oil Corporation

Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.

Share on Social Networks: